Identification of luminal breast cancers that establish a tumor-supportive macroenvironment defined by proangiogenic platelets and bone marrow-derived cells.
暂无分享,去创建一个
A. Richardson | S. Signoretti | Timothy Marsh | A. Greene-Colozzi | E. Battinelli | B. A. Markens | S. McAllister | Victoria Brown | Z. Castaño | Hanna S. Kuznetsov | Samantha A. Hay | April Greene-Colozzi
[1] Shui Wang,et al. Meta‐analysis on the association between non‐steroidal anti‐inflammatory drug use and ovarian cancer , 2013, British journal of clinical pharmacology.
[2] M. Teh,et al. Aspirin and non-aspirin non-steroidal anti-inflammatory drug use and risk of lung cancer. , 2012, Lung cancer.
[3] F. Shojaei,et al. Anti-angiogenesis therapy in cancer: current challenges and future perspectives. , 2012, Cancer letters.
[4] M. Kerin,et al. Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype , 2012, Breast Cancer Research and Treatment.
[5] M. Thun,et al. The role of aspirin in cancer prevention , 2012, Nature Reviews Clinical Oncology.
[6] P. Rothwell,et al. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials , 2012, The Lancet.
[7] O. Dekkers,et al. Use of Aspirin postdiagnosis improves survival for colon cancer patients , 2012, British Journal of Cancer.
[8] R. D'Amato,et al. VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients , 2012, Angiogenesis.
[9] W. Chiu,et al. Paraneoplastic thrombocytosis in ovarian cancer. , 2012, The New England journal of medicine.
[10] S. McAllister,et al. The tumor macroenvironment and systemic regulation of breast cancer progression. , 2011, The International journal of developmental biology.
[11] Richard O Hynes,et al. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. , 2011, Cancer cell.
[12] L. Kiemeney,et al. Better survival in patients with metastasised kidney cancer after nephrectomy: a population-based study in the Netherlands. , 2011, European journal of cancer.
[13] J. Italiano,et al. Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis. , 2011, Blood.
[14] Mithat Gönen,et al. The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors. , 2011, The Journal of clinical investigation.
[15] M. Dewhirst,et al. Upregulation of VEGF-A and CD24 Gene Expression by the tGLI1 Transcription Factor Contributes to the Aggressive Behavior of Breast Cancer Cells , 2011, Oncogene.
[16] M. O. oude Egbrink,et al. The Role of Blood Platelets in Tumor Angiogenesis , 1985 .
[17] R. Twombly. Avastin's uncertain future in breast cancer treatment. , 2011, Journal of the National Cancer Institute.
[18] C. Hill,et al. Levels of circulating CD45dimCD34+VEGFR2+ progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors , 2011, British Journal of Cancer.
[19] Anne E Carpenter,et al. Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice. , 2011, The Journal of clinical investigation.
[20] Laurie J. Gay,et al. Contribution of platelets to tumour metastasis , 2011, Nature Reviews Cancer.
[21] J. Hartwig,et al. Cytoskeletal mechanics of proplatelet maturation and platelet release , 2010, The Journal of cell biology.
[22] Jorge S Reis-Filho,et al. Triple-negative breast cancer. , 2010, The New England journal of medicine.
[23] R. Matkowski,et al. Serum Vascular Endothelial Growth Factors A, C and D in Human Breast Tumors , 2010, Pathology & Oncology Research.
[24] N. Almog. Molecular mechanisms underlying tumor dormancy. , 2010, Cancer letters.
[25] R. Weinberg,et al. Tumor-host interactions: a far-reaching relationship. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] Kornelia Polyak,et al. Heterogeneity for Stem Cell–Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer , 2010, Clinical Cancer Research.
[27] Hua Yu,et al. STATs in cancer inflammation and immunity: a leading role for STAT3 , 2009, Nature Reviews Cancer.
[28] V. Tjan-Heijnen,et al. 5005 Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis , 2009 .
[29] Dingcheng Gao,et al. The role of bone-marrow-derived cells in tumor growth, metastasis initiation and progression. , 2009, Trends in molecular medicine.
[30] C. Wood,et al. Cytoreductive nephrectomy for metastatic RCC in the era of targeted therapy , 2009, Nature Reviews Urology.
[31] H. Lee,et al. Expression of CD24 in clear cell renal cell carcinoma and its prognostic significance. , 2008, Urology.
[32] R. Weinberg,et al. Systemic Endocrine Instigation of Indolent Tumor Growth Requires Osteopontin , 2008, Cell.
[33] Ruud H. Brakenhoff,et al. Detection, clinical relevance and specific biological properties of disseminating tumour cells , 2008, Nature Reviews Cancer.
[34] J. Folkman,et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. , 2008, Blood.
[35] James D Iglehart,et al. Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes. , 2007, Cancer cell.
[36] G. Cagney,et al. Moderation of the platelet releasate response by aspirin. , 2007, Blood.
[37] S. Rafii,et al. Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] T. Sørlie,et al. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms , 2006, BMC Genomics.
[39] Dennis C. Sgroi,et al. Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.
[40] C. Pilarsky,et al. CD24 expression is a new prognostic marker in breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[41] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[42] Koichi Hattori,et al. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? , 2002, Nature Reviews Cancer.
[43] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[44] P. Altevogt,et al. CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. , 1997, Blood.
[45] J. A. Andersen,et al. Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. , 1987, British Journal of Cancer.
[46] Hua Yu,et al. Tumour immunology: Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment , 2007, Nature Reviews Immunology.
[47] W. Hahn,et al. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. , 2001, Genes & development.